- Home
- LPSN vs TLSA Comparison
LPSN vs TLSA Comparison
Compare LPSN & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- TLSA
- Stock Information
- Founded
- LPSN 1995
- TLSA 2013
- Country
- LPSN United States
- TLSA United Kingdom
- Employees
- LPSN N/A
- TLSA N/A
- Industry
- LPSN EDP Services
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- LPSN Technology
- TLSA Health Care
- Exchange
- LPSN Nasdaq
- TLSA Nasdaq
- Market Cap
- LPSN 75.3M
- TLSA 87.8M
- IPO Year
- LPSN 2000
- TLSA 2000
- Fundamental
- Price
- LPSN $0.93
- TLSA $1.43
- Analyst Decision
- LPSN Hold
- TLSA
- Analyst Count
- LPSN 5
- TLSA 0
- Target Price
- LPSN $0.98
- TLSA N/A
- AVG Volume (30 Days)
- LPSN 1.7M
- TLSA 1.4M
- Earning Date
- LPSN 03-05-2025
- TLSA 03-18-2025
- Dividend Yield
- LPSN N/A
- TLSA N/A
- EPS Growth
- LPSN N/A
- TLSA N/A
- EPS
- LPSN N/A
- TLSA N/A
- Revenue
- LPSN $312,474,000.00
- TLSA N/A
- Revenue This Year
- LPSN N/A
- TLSA N/A
- Revenue Next Year
- LPSN $1.72
- TLSA N/A
- P/E Ratio
- LPSN N/A
- TLSA N/A
- Revenue Growth
- LPSN N/A
- TLSA N/A
- 52 Week Low
- LPSN $0.45
- TLSA $0.41
- 52 Week High
- LPSN $2.08
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- LPSN 36.94
- TLSA 63.29
- Support Level
- LPSN $0.84
- TLSA $1.25
- Resistance Level
- LPSN $1.11
- TLSA $1.91
- Average True Range (ATR)
- LPSN 0.08
- TLSA 0.25
- MACD
- LPSN -0.02
- TLSA 0.04
- Stochastic Oscillator
- LPSN 23.82
- TLSA 56.76
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation.. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.